Page last updated: 2024-12-08

cycloartane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cycloartane : A triterpene that is lanostane in which there is a methylene bridge between the 5- and 9-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160497
CHEBI ID37778
MeSH IDM0226543

Synonyms (15)

Synonym
9beta,19-cyclolanostane
CHEBI:37778
9,19-cyclolanostane
cycloartane
511-64-8
4,4,14-trimethyl-9,19-cyclo-5alpha,9beta-cholestane
cycloorthane
tj8jf2m6u6 ,
unii-tj8jf2m6u6
Q27117259
DTXSID10965378
(1s,3r,8s,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane
(5s-(5.alpha.,8.beta.,9r*,10s*,13.beta.,14.alpha.,17.beta.(s*)))-17-(1,5-dimethylhexyl)tetradecahydro-4,4,13,14-tetramethyl-1h,19h-cyclopropa(9,10)cyclopenta(a)phenanthrene
1h,19h-cyclopropa(9,10)cyclopenta(a)phenanthrene, 17-(1,5-dimethylhexyl)tetradecahydro-4,4,13,14-tetramethyl-, (5s-(5.alpha.,8.beta.,9r*,10s*,13.beta.,14.alpha.,17.beta.(s*))-
9,19-cyclo-9.beta.-lanostane

Research Excerpts

Effects

ExcerptReferenceRelevance
"Six cycloartane triterpenes have been isolated from the red alga Galaxaura sp. "( Cycloartanes from the red alga Galaxaura sp.
Che, CT; Zhang, WH; Zhong, HM, 2005
)
2.33

Dosage Studied

ExcerptRelevanceReference
" None of the compounds were active at low dosage levels (0."( Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species.
Bedir, E; Calis, I; Khan, IA; Pasco, DS; Pugh, N, 2000
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpeneA C30 terpene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (211)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (2.84)18.2507
2000's49 (23.22)29.6817
2010's124 (58.77)24.3611
2020's32 (15.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.54 (24.57)
Research Supply Index5.38 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index1.80 (0.95)

This Compound (28.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other211 (98.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]